
Keywords: ATII; alveolar epithelial type II; AIIt; annexin A2 heterotetramer; APC; activated protein C; BALF; broncho-alveolar lavage fluid; DAD; diffuse alveolar damage; EGF; epidermal growth factor; ECM; extracellular matrix; FAK; focal adhesion kinase; FV; facto